Smaller doses for perioral treatment than for higher facial applications are used as the oral musculature responds additional strongly to a similar BTX-A dosing. Only one planning of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole sign and FDA approval lies in treatments of cervical dystonia. Considered one of https://alexishragn.governor-wiki.com/1556874/facts_about_botulinum_toxin_vs_botox_revealed